Tiburon, California
United States
48
2025-11-13
The entities that hold a legal rights for patent applications filed by inventor Thanos Christopher D.:
Christopher D. Thanos from Tiburon, US has applied for patents for these inventions. The list has both pending applications and granted patents:
ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#2 | 2025-10-02MODIFIED FC PROTEINS COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES OF THE SAME, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE
#3 | 2025-07-24MODIFIED AMINO ACIDS
#4 | 2025-01-02ANTIBODIES COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE
#5 | 2024-09-05IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT
#6 | 2023-06-29COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME
#7 | 2023-05-04Modified amino acids
#8 | 2023-04-13ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE
#9 | 2023-03-09Engineered immunostimulatory bacterial strains and uses thereof
#10 | 2022-12-01IMMUNOSTIMULATORY BACTERIA DELIVERY PLATFORMS AND THEIR USE FOR DELIVERY OF THERAPEUTIC PRODUCTS
#11 | 2022-09-08Engineered immunostimulatory bacterial strains and uses thereof
#12 | 2022-05-19IMMUNOSTIMULATORY BACTERIA DELIVERY PLATFORMS AND THEIR USE FOR DELIVERY OF THERAPEUTIC PRODUCTS
#13 | 2022-05-05IMMUNOSTIMULATORY BACTERIA ENGINEERED TO COLONIZE TUMORS, TUMOR-RESIDENT IMMUNE CELLS, AND THE TUMOR MICROENVIRONMENT
#14 | 2022-04-21IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS
#15 | 2022-04-14Engineered immunostimulatory bacterial strains and uses thereof
#16 | 2022-01-20ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#17 | 2021-02-25EXPRESSION OF BIOLOGICALLY ACTIVE PROTEINS IN A BACTERIAL CELL-FREE SYNTHESIS SYSTEM USING BACTERIAL CELLS TRANSFORMED TO EXHIBIT ELEVATED LEVELS OF CHAPERONE EXPRESSION
#18 | 2021-02-04ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#19 | 2020-11-19Modified amino acids
#20 | 2020-10-22USE OF LAMBDA-GAM PROTEIN IN RIBOSOMAL DISPLAY TECHNOLOGY
#21 | 2020-09-24Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
#22 | 2020-09-10Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
#23 | 2020-08-27Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
#24 | 2020-07-09Engineered immunostimulatory bacterial strains and uses thereof
#25 | 2020-03-05Engineered immunostimulatory bacterial strains and uses thereof
#26 | 2020-02-27Proteolytic inactivation of select proteins in bacterial extracts for improved expression
#27 | 2019-05-30Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression
#28 | 2019-02-14Modified amino acids
#29 | 2019-01-17Engineered immunostimulatory bacterial strains and uses thereof
#30 | 2018-08-02Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
#31 | 2018-05-24Use of lambda-gam protein in ribosomal display technology
#32 | 2018-02-08Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
#33 | 2017-12-21Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
#34 | 2017-12-21Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
#35 | 2017-10-05Proteolytic inactivation of select proteins in bacterial extracts for improved expression
#36 | 2017-09-21Modified amino acids
#37 | 2017-09-14Modified amino acids
#38 | 2017-06-15Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
#39 | 2016-09-22COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME
#40 | 2016-03-10SELECTION OF FAB FRAGMENTS USING RIBOSOMAL DISPLAY TECHNOLOGY
#41 | 2016-03-03Use of LAMBDA-GAM protein in ribosomal display technology
#42 | 2015-09-17Proteolytic inactivation of select proteins in bacterial extracts for improved expression
#43 | 2015-03-12MODIFIED ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF
#44 | 2015-01-15Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
#45 | 2014-10-23Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression
#46 | 2014-03-06Modified amino acids
#47 | 2014-02-20Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
#48 | 2014-02-13Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
651791 ⎘